Atlas Trials

Safety and Efficacy of BAFFR CART for Relapsed/ Refractory Neuromyelitis Optica Spectrum Disorder

Clinical trial NCT06561009 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06561009
Sponsor
Tianjin Medical University General Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neuromyelitis Optica Spectrum Disorder
Start date
2025-12-01
Primary completion
2027-10-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.